cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-2072Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕOPINION ON A PROBLEMНовые нелекарственные методы лечения резистентной артериальной гипертензииNew non-pharmaceutical methods for the treatment of resistant arterial hypertensionРодионовА. В.RodionovA. V.

доцент кафедры факультетской терапии № 1 лечебного факультета

Москва, Тел.: +7 (499) 248–57–90

Moscow

ftk-consult@mma.ruШумиловаИ. Э.ShumilovaI. E.

студентка 5 курса

Москва

Moscow

МаколкинВ. И.MakolkinV. I.

профессор кафедры факультетской терапии No1 лечебного факультета

Москва

Moscow

Первый Московский государственный медицинский университет им. И. М. СеченоваРоссияI. M. Sechenov First Moscow State Medical UniversityRussian Federation201101011970108103106Copyright © Родионов А.В., Шумилова И.Э., Маколкин В.И., 19701970Родионов А.В., Шумилова И.Э., Маколкин В.И.Rodionov A.V., Shumilova I.E., Makolkin V.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/2072

В статье представлены новые немедикаментозные методы лечения резистентной артериальной гипертензии – стимуляция каротидного синуса и почечная симпатическая денервация. Приводится анализ клинических исследований эффективности и безопасности новых методов лечения.

The review presents new non-pharmaceutical methods for the treatment of resistant arterial hypertension, such as carotid sinus stimulation and renal sympathetic denervation. The authors analyze the results of the clinical studies on efficacy and safety of these new methods.

артериальная гипертензиястимуляция каротидного синусапочечная симпатическая денервацияArterial hypertensioncarotid sinus stimulationrenal sympathetic denervationReferencesCalhoun DA, Jones D, Textor S, et al. Resistant Hypertension: Diagnosis, Evaluation and treatment. Hypertension 2008; 51: 1403–19.Calhoun DA, Jones D, Textor S, et al. Resistant Hypertension: Diagnosis, Evaluation and treatment. Hypertension 2008; 51: 1403–19.Lloyd-Jones DM, Evans JC, Larson MG, et al Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–9.Lloyd-Jones DM, Evans JC, Larson MG, et al Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–9.Scheffers IM, Kroon AA, de Leeuw PW. Carotid Baroreflex Activation: Past, Present, and Future. Curr Hypertens Rep 2010; 12: 61–6.Scheffers IM, Kroon AA, de Leeuw PW. Carotid Baroreflex Activation: Past, Present, and Future. Curr Hypertens Rep 2010; 12: 61–6.Kubicek WG, Kottke FJ, Laker DJ, Visscher MB. Adaptation in the pressor-receptor reflex mechanisms in experimental neurogenic hypertension. Am J Physiol 1953; 175: 380–2.Kubicek WG, Kottke FJ, Laker DJ, Visscher MB. Adaptation in the pressor-receptor reflex mechanisms in experimental neurogenic hypertension. Am J Physiol 1953; 175: 380–2.Bristow JD, Honour AJ, Pickering GW, et al. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39: 48–54.Bristow JD, Honour AJ, Pickering GW, et al. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39: 48–54.Bilgutay AM, Lillehei CW. Treatment of hypertension with an implantable electronic device. JAMA 1965; 191: 649–53.Bilgutay AM, Lillehei CW. Treatment of hypertension with an implantable electronic device. JAMA 1965; 191: 649–53.Carlsten A, Folkow B, Grimby G, et al. Cardiovascular effects of direct stimulation of the carotid sinus nerve in man. Acta Physiol Scand 1958; 44: 138–45.Carlsten A, Folkow B, Grimby G, et al. Cardiovascular effects of direct stimulation of the carotid sinus nerve in man. Acta Physiol Scand 1958; 44: 138–45.Braunwald E, Epstein SE, Glick G, et al. Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med 1967; 277: 1278–83.Braunwald E, Epstein SE, Glick G, et al. Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med 1967; 277: 1278–83.Parsonnet V, Myers GH, Holcomb WG, Zucker IR. Radiofrequency stimulation of the carotid baroreceptors in the treatment of hypertension. Surg Forum 1966; 17: 125–7.Parsonnet V, Myers GH, Holcomb WG, Zucker IR. Radiofrequency stimulation of the carotid baroreceptors in the treatment of hypertension. Surg Forum 1966; 17: 125–7.Neistadt A, Schwartz SI. Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension. Surgery 1967; 61: 923–31.Neistadt A, Schwartz SI. Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension. Surgery 1967; 61: 923–31.Scheffers IM, Kroon AA, Schmidli J. Novel baroreflex activation therapy in resistant hypertension. J Am Coll Cardiol 2010; 56: 1254–8.Scheffers IM, Kroon AA, Schmidli J. Novel baroreflex activation therapy in resistant hypertension. J Am Coll Cardiol 2010; 56: 1254–8.Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1953; 1: 403–8.Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1953; 1: 403–8.DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11: 197–200.DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11: 197–200.Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275–81Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275–81Schlaich M, Krum H, Walton T, et al. Two-year durability of blood pressure reduction with catheter-based renal sympathetic denervation.J Hypertension 2010; 28: e446.Schlaich M, Krum H, Walton T, et al. Two-year durability of blood pressure reduction with catheter-based renal sympathetic denervation.J Hypertension 2010; 28: e446.Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903–9Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903–9

The authors declare that there are no conflicts of interest present.